These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1349452)

  • 21. Immunocytochemical localization and identification of prosomatostatin gene products in medullary carcinoma of human thyroid gland.
    Scopsi L; Ferrari C; Pilotti S; Holst JJ; Rehfeld JF; Fossati G; Rilke F
    Hum Pathol; 1990 Aug; 21(8):820-30. PubMed ID: 1974875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medullary carcinoma of the thyroid gland. Studies of thyrocalcitonin in plasma and tumor extracts.
    Tashjian AH; Melvin EW
    N Engl J Med; 1968 Aug; 279(6):279-83. PubMed ID: 5660301
    [No Abstract]   [Full Text] [Related]  

  • 23. Calcitonin production: an examination of the regulatory effects of extracellular calcium and 1,25-dihydroxyvitamin D3.
    Cote GJ; Huang ES; Gagel RF
    Horm Metab Res Suppl; 1989; 21():15-8. PubMed ID: 2807150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of 17 beta-estradiol on calcitonin secretion and content in a human medullary thyroid carcinoma cell line.
    Lazaretti-Castro M; Grauer A; Mekonnen Y; Raue F; Ziegler R
    J Bone Miner Res; 1991 Nov; 6(11):1191-5. PubMed ID: 1805543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cysteine proteinase inhibitor in cultured human medullary thyroid carcinoma cells.
    Barka T; van der Noen H; Patil S
    Lab Invest; 1992 Jun; 66(6):691-700. PubMed ID: 1602739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melanin-producing medullary thyroid carcinoma with glandular differentiation.
    Kimura N; Ishioka K; Miura Y; Sasano N; Takaya K; Mouri T; Kimura T; Nakazato Y; Yamada R
    Acta Cytol; 1989; 33(1):61-6. PubMed ID: 2644744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different mechanisms of calcitonin, calcitonin gene-related peptide, and somatostatin regulation by glucocorticoids in a cell culture of human medullary thyroid carcinoma.
    Cote GJ; Gagel RF
    Henry Ford Hosp Med J; 1987; 35(2-3):149-52. PubMed ID: 2891648
    [No Abstract]   [Full Text] [Related]  

  • 28. Establishment and characterization of continuous cell line MTC-SK derived from a human medullary thyroid carcinoma.
    Pfragner R; Höfler H; Behmel A; Ingolic E; Walser V
    Cancer Res; 1990 Jul; 50(13):4160-6. PubMed ID: 1972348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin receptors and somatostatin content in medullary thyroid carcinomas.
    Reubi JC; Chayvialle JA; Franc B; Cohen R; Calmettes C; Modigliani E
    Lab Invest; 1991 Apr; 64(4):567-73. PubMed ID: 1673164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characterization and calcitonin secretion of a human well differentiated C-cell tumor cell line].
    Kameya T; Kadoya K; Iguchi H
    Hum Cell; 1989 Sep; 2(3):231-7. PubMed ID: 2519210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of calcitriol and its analogues on proliferation and hormone expression in cultured cells of thyroid medullary carcinomas.
    Zabel M; Flig K; Gebarowska E; Surdyk-Zasada J
    Folia Morphol (Warsz); 2003 Nov; 62(4):463-5. PubMed ID: 14655142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Norepinephrine induced calcitonin secretion in rat medullary thyroid carcinoma 6-23 cells: interaction between intracellular calcium and cAMP.
    Zink-Lorenz A; Komitowska J; Raue F
    Exp Clin Endocrinol Diabetes; 1996; 104(1):43-9. PubMed ID: 8750570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in calcium metabolism: application to medullary carcinoma of the thyroid and hyperparathyroidism.
    Kaplan EL
    Surg Annu; 1973; 5():97-119. PubMed ID: 4602211
    [No Abstract]   [Full Text] [Related]  

  • 34. Morphological changes of human thyroid medullary carcinoma cell line treated with calcium channel antagonist nifedipine.
    Nakamura A; Kakudo K; Watanabe K; Satoh R; Shimaoka K
    Kitasato Arch Exp Med; 1988 Dec; 61(4):195-200. PubMed ID: 3253470
    [No Abstract]   [Full Text] [Related]  

  • 35. Medullary thyroid carcinoma and hormones.
    Cohen R; Quidville V; Bihan H
    Ann Med Interne (Paris); 2003 Mar; 154(2):109-16. PubMed ID: 12746649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoassay of calcitonin in rat medullary thyroid carcinoma.
    Deftos LJ; Boorman GA; Roos BA
    Horm Metab Res; 1976 Jan; 8(1):83-4. PubMed ID: 1248795
    [No Abstract]   [Full Text] [Related]  

  • 37. Discordance between plasma calcitonin and tumor-cell mass in medullary thyroid carcinoma.
    Trump DL; Mendelsohn G; Baylin SB
    N Engl J Med; 1979 Aug; 301(5):253-5. PubMed ID: 449992
    [No Abstract]   [Full Text] [Related]  

  • 38. Establishment of a calcitonin-producing rat medullary thyroid carcinoma cell line. I. Morphological studies of the tumor and cells in culture.
    Zeytinoğlu FN; DeLellis RA; Gagel RF; Wolfe HJ; Tashjian AH
    Endocrinology; 1980 Aug; 107(2):509-15. PubMed ID: 6248326
    [No Abstract]   [Full Text] [Related]  

  • 39. Somatostatin elaboration by monolayer cell cultures derived from transplantable rat medullary thyroid carcinoma: synergistic stimulatory effects of glucagon and calcium.
    Aron DC; Muszynski M; Birnbaum RS; Sabo SW; Roos BA
    Endocrinology; 1981 Dec; 109(6):1830-4. PubMed ID: 6118254
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased plasma and tumor somatostatin-like immunoreactivity in medullary thyroid carcinoma and small cell lung cancer.
    Roos BA; Lindall AW; Ells J; Elde R; Lambert PW; Birnbaum RS
    J Clin Endocrinol Metab; 1981 Feb; 52(2):187-94. PubMed ID: 6109732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.